Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FHLC vs. ETHSX: which is better?

Bottom line

FHLC vs ETHSX: the short answer

FHLC (Fidelity MSCI Health Care Index ETF) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) share a meaningful slice of their top holdings — about 63% by weight.

But FHLC is far broader, holding 337 positions to 42 for ETHSX, so beyond the top names it adds exposure ETHSX doesn't have.

FHLC is cheaper at 0.084% vs 1.18% — a difference of $110 a year per $10,000 invested.

Over five years, FHLC returned +7.2% a year vs +5.3% for ETHSX (reporting dates differ).

ETHSX has a front-end sales load of up to 5.25%; the other does not.

Updated Nov 19, 2026

FHLC vs ETHSX side by side

FHLCETHSX
TypeETFMutual fund
Fund familyFidelityMorgan Stanley
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.084%1.18%
Annual cost per $10k$8.4$118
10-yr cost on $10k (prospectus)$108$1,911
Max front loadNone5.25%
12b-1 fee0%0.25%
1-yr return+2.6%−1.9%
5-yr return (annualized)+7.2%+5.3%
10-yr return (annualized)+8.8%+6.4%
Best quarter+16.4%+14.2%
Worst quarter−13.1%−12.1%
Net assets (fund)$3.3B$757.9M
Number of holdings33742
Portfolio turnover3%3%
Returns as ofNov 30, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFHLCETHSXDifference
2024+2.6%+3.5%−0.9%
2023+2.5%+5.7%−3.2%
2022−5.5%−9.4%+4.0%
2021+20.4%+22.1%−1.7%
2020+18.1%+13.0%+5.1%
2019+21.9%+26.0%−4.1%
2018+5.5%+6.0%−0.5%
2017+23.3%+16.2%+7.1%
2016−3.3%−14.9%+11.6%
2015+7.0%+8.4%−1.3%

Source: Fund prospectus bar charts

Holdings overlap

14 of FHLC's top 25 holdings also appear in ETHSX's top 25.

Shared top holdings
HoldingFHLCETHSX
Eli Lilly & Co13.35%12.47%
Johnson & Johnson8.93%6.45%
AbbVie Inc6.42%6.46%
UnitedHealth Group Inc5.44%5.49%
Merck & Co Inc4.66%5.08%
Thermo Fisher Scientific Inc3.09%2.79%
Abbott Laboratories2.66%1.65%
Gilead Sciences Inc2.34%3.34%
Bristol-Myers Squibb Co1.93%4.25%
Intuitive Surgical Inc1.82%2.72%
Vertex Pharmaceuticals Inc1.76%3.38%
Stryker Corp1.62%2.21%
Medtronic PLC1.59%1.80%
Boston Scientific Corp1.00%2.18%

Source: SEC Form N-PORT

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

ETHSX top 10

  1. Eli Lilly & Co — 12.47%
  2. AbbVie Inc — 6.46%
  3. Johnson & Johnson — 6.45%
  4. AstraZeneca PLC — 6.24%
  5. UnitedHealth Group Inc — 5.49%
  6. Roche Holding AG — 5.44%
  7. Merck & Co Inc — 5.08%
  8. Bristol-Myers Squibb Co — 4.25%
  9. Vertex Pharmaceuticals Inc — 3.38%
  10. Gilead Sciences Inc — 3.34%

FAQ

What is the difference between FHLC and ETHSX?
FHLC (Fidelity MSCI Health Care Index ETF) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) share a meaningful slice of their top holdings — about 63% by weight. But FHLC is far broader, holding 337 positions to 42 for ETHSX, so beyond the top names it adds exposure ETHSX doesn't have.
Which is cheaper, FHLC or ETHSX?
FHLC has the lower expense ratio (0.084%).
Should I own both FHLC and ETHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.